Top Nanotechnology Stocks To Add to Your Watchlist - May 29th

OSI Systems, NVE, and Biodexa Pharmaceuticals are the three Nanotechnology stocks to watch today, according to MarketBeat's stock screener tool. Nanotechnology stocks are shares of publicly traded companies that research, develop or commercialize materials, devices and processes engineered at the nanoscale (typically 1–100 nanometers). By investing in these equities, shareholders gain exposure to innovations in areas such as electronics, medicine, energy and materials science that leverage the unique properties of nanomaterials. These companies had the highest dollar trading volume of any Nanotechnology stocks within the last several days.

OSI Systems (OSIS)

OSI Systems, Inc. designs and manufactures electronic systems and components. It operates in three segments: Security, Healthcare, and Optoelectronics and Manufacturing. The Security segment offers baggage and parcel inspection, cargo and vehicle inspection, hold baggage and people screening, radiation monitoring, explosive and narcotics trace detection systems, and optical inspection systems under the Rapiscan name.

OSI Systems stock traded up $3.39 during midday trading on Thursday, reaching $219.39. 151,817 shares of the company traded hands, compared to its average volume of 193,824. OSI Systems has a 12 month low of $129.18 and a 12 month high of $234.59. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.88 and a quick ratio of 1.25. The firm has a market capitalization of $3.68 billion, a price-to-earnings ratio of 28.15, a price-to-earnings-growth ratio of 1.81 and a beta of 1.28. The business has a 50 day moving average of $205.77 and a two-hundred day moving average of $190.21.

Read Our Latest Research Report on OSIS

NVE (NVEC)

NVE Corporation develops and sells devices that use spintronics, a nanotechnology that relies on electron spin to acquire, store, and transmit information in the United States and internationally. The company manufactures spintronic products, including sensors and couplers for use in acquiring and transmitting data.

Shares of NASDAQ NVEC traded up $0.63 during mid-day trading on Thursday, reaching $73.40. The company's stock had a trading volume of 11,150 shares, compared to its average volume of 24,775. The firm has a market capitalization of $355.04 million, a PE ratio of 23.68 and a beta of 1.09. NVE has a 52 week low of $51.50 and a 52 week high of $89.98. The stock has a fifty day moving average of $63.18 and a two-hundred day moving average of $71.02.

Read Our Latest Research Report on NVEC

Biodexa Pharmaceuticals (BDRX)

Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of Type 1 diabetes and rare/orphan cancers of the brain. Its lead product candidate Tolimidone, a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes.

Shares of NASDAQ:BDRX remained flat at $1.05 during midday trading on Thursday. 326,836 shares of the company were exchanged, compared to its average volume of 1,867,356. The company's 50 day moving average is $1.41 and its two-hundred day moving average is $3.16. Biodexa Pharmaceuticals has a 12-month low of $1.01 and a 12-month high of $41.50.

Read Our Latest Research Report on BDRX